OR51A9P

Across TCGA pan-cancer cohorts, OR51A9P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR51A9P data layer.

The strongest signal is observed in acute myeloid leukemia (LAML), where higher OR51A9P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR51A9P expression acts as an unfavorable survival marker, although some lineages such as KIRC and PRAD show a favorable association.

LAML, CHOL, and SARC are the cancer types where OR51A9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LAML	DFS	Tertile	All	0.334	0.601	.019	36	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	36	view →
SARC	DFS	Tertile	All	0.192	0.377	.002	27	view →
ACC	OS	Tertile	II,III,IV	0.135	0.678	.017	18	view →
SKCM	OS	Tertile	All	0.179	0.350	.006	18	view →
TGCT	DFS	Tertile	III,IV	0.017	0.923	.021	18	view →
KIRC	DFS	Median	III,IV	0.706	0.583	.023	14	view →
READ	OS	Quartile	All	0.829	0.940	.020	12	view →
PRAD	DFS	Tertile	All	0.877	0.728	.021	10	view →
KICH	OS	Tertile	III,IV	1.000	0.543	.024	8	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR51A9P–LAML (DFS)

Open the LAML breakdown →